One major exception is Li–Fraumeni syndrome, where germline TP53 mutations predispose individuals to a unique tumor spectrum that includes soft tissue sarcomas, such as RMS, and bone tumors (Guha and Malkin, 2017; Malkin, 2011). This evidence concerns the gene TP53 and neoplasm.